Amelie G. Ramirez, DrPH, MPH, director of Salud America! at UT Health San Antonio and a leading health disparities researcher, has been selected to serve as the 2021-2022 chair of the Women in Cancer Research Council of the American Association for Cancer Research (AACR).

It’s a medical conundrum. Ionizing radiation, which at first extends the survival of glioblastoma patients after surgery, may later, ironically, help drive the brain cancer’s aggressive, untreatable recurrence. Dr. Sandeep Burma and a team of investigators at the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, are studying companion treatments to see if any can eliminate this Jekyll and Hyde property of ionizing radiation.

The newer procedure is called robotic retroperitoneal lymph node dissection, or robotic RPLND. Although the procedure has been previously reported, Mays Cancer Center developed technical improvements to make it safer, more effective and applicable in new indications.

Yoga improved physical and mental well-being and promoted a robust immune response in a randomized clinical trial of men with prostate cancer.

Researchers from the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, will present results of multiple lines of study Dec. 7-10 during the 2021 San Antonio Breast Cancer Symposium.

Ruben A. Mesa, MD, FACP, executive director of the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, has played a key role as both an investigator and aiding the drug development for the past eight years to get RoPEG INFa2b (besremi) approved in PV.

Cancer survivorship is an emerging area of research, yet the survivorship experience differs significantly between racial-ethnic groups. Latinos with cancer, for example, face a challenging survivorship journey marked by advanced disease, poor quality of life, and stressful socioeconomic inequities. The Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, is working […]